Opko Health Company Leadership
| OPK Stock | USD 1.59 0.03 1.92% |
About 75% of Opko Health's corporate insiders are selling. The analysis of the overall insider sentiment regarding Opko Health suggests that many insiders are alarmed. Opko Health employs about 3.9 K people. The company is managed by 16 executives with a total tenure of roughly 34 years, averaging almost 2.0 years of service per executive, having 245.63 employees per reported executive.
| Phillip Frost Chairman Chairman of the Board, CEO |
| Akhtar Ashfaq President Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division |
Opko Health's Insider Buying Vs Selling
25
Selling | Buying |
Latest Trades
| 2024-11-29 | Phillip Md Et Al Frost | Acquired 199072 @ 1.53 | View | ||
| 2024-11-22 | Phillip Md Et Al Frost | Acquired 100000 @ 1.59 | View | ||
| 2024-11-14 | Phillip Md Et Al Frost | Acquired 100000 @ 1.62 | View | ||
| 2024-11-08 | Phillip Md Et Al Frost | Acquired 280183 @ 1.5 | View | ||
| 2024-08-19 | Opko Health, Inc. | Disposed 50000 @ 34.49 | View | ||
| 2024-08-15 | Opko Health, Inc. | Disposed 39824 @ 33.08 | View | ||
| 2024-08-12 | Opko Health, Inc. | Disposed 59787 @ 33.95 | View | ||
| 2024-08-08 | Opko Health, Inc. | Disposed 100000 @ 31.82 | View | ||
| 2024-08-06 | Opko Health, Inc. | Disposed 12994 @ 29.35 | View | ||
| 2024-07-31 | Opko Health, Inc. | Disposed 88839 @ 33.5 | View | ||
| 2024-07-29 | Opko Health, Inc. | Disposed 50000 @ 33.86 | View | ||
| 2024-07-26 | Opko Health, Inc. | Disposed 60000 @ 33.85 | View | ||
| 2024-07-24 | Opko Health, Inc. | Disposed 75000 @ 33.72 | View | ||
| 2024-07-22 | Opko Health, Inc. | Disposed 50000 @ 32.61 | View | ||
| 2024-07-19 | Opko Health, Inc. | Disposed 25000 @ 32.29 | View | ||
| 2024-07-17 | Opko Health, Inc. | Disposed 25000 @ 32.93 | View | ||
| 2024-07-05 | Opko Health, Inc. | Disposed 36118 @ 28.24 | View | ||
| 2024-07-03 | Opko Health, Inc. | Disposed 14082 @ 28.23 | View | ||
| 2024-07-01 | Opko Health, Inc. | Disposed 50000 @ 26.63 | View | ||
| 2024-05-23 | Phillip Md Et Al Frost | Acquired 100000 @ 1.27 | View |
Monitoring Opko Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Opko |
Opko Health Management Team Effectiveness
The company has Return on Asset of (0.0897) % which means that on every $100 spent on assets, it lost $0.0897. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0939) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.41. The value of Return On Capital Employed is expected to slide to -0.09. At this time, Opko Health's Liabilities And Stockholders Equity is quite stable compared to the past year. Change To Liabilities is expected to grow at the current pace this year, although the value of Total Current Liabilities will most likely fall to about 103.9 M.Common Stock Shares Outstanding is expected to rise to about 789.4 M this year, although the value of Net Loss is projected to rise to (280.8 M).
Opko Health Workforce Comparison
Opko Health is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 52,514. Opko Health holds roughly 3,930 in number of employees claiming about 7% of equities under Health Care industry.
The company has Net Profit Margin of (0.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.62) %, which entails that for every $100 of revenue, it lost $0.62. Opko Health Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Opko Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Phillip Frost over a week ago Acquisition by Phillip Frost of 199072 shares of Opko Health at 1.534 subject to Rule 16b-3 | ||
Phillip Frost over two weeks ago Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.59 subject to Rule 16b-3 | ||
Phillip Frost over three weeks ago Acquisition by Phillip Frost of 14800 shares of Opko Health at 1.78 subject to Rule 16b-3 | ||
Rubin Steven D over a month ago Acquisition by Rubin Steven D of 10000 shares of Opko Health at 1.3 subject to Rule 16b-3 | ||
Phillip Frost over two months ago Acquisition by Phillip Frost of tradable shares of Opko Health at 1.15 subject to Rule 16b-3 | ||
Phillip Frost over three months ago Acquisition by Phillip Frost of 770 shares of Opko Health at 1.265 subject to Rule 16b-3 | ||
Adam Logal over three months ago Acquisition by Adam Logal of 437500 shares of Opko Health subject to Rule 16b-3 | ||
Nabel Gary J. over three months ago Acquisition by Nabel Gary J. of 437500 shares of Opko Health subject to Rule 16b-3 |
Opko Health Notable Stakeholders
An Opko Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Opko Health often face trade-offs trying to please all of them. Opko Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Opko Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Elias MD | President Chairman | Profile | |
| Phillip Frost | Chairman of the Board, CEO | Profile | |
| David Okrongly | President Diagnostics | Profile | |
| Antonio Cruz | President Therapeutics | Profile | |
| Hans Berner | President Iberoamerica | Profile | |
| Akhtar Ashfaq | Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division | Profile | |
| Adam Logal | CFO, Chief Accounting Officer, Sr. VP and Treasurer | Profile | |
| Arie Gutman | Pres API | Profile | |
| Dr MBA | Vice Officer | Profile | |
| FACP FASN | Senior Renal | Profile | |
| JD Esq | Chief Laboratories | Profile | |
| Charles Bishop | Chief Renal | Profile | |
| James DeMarco | VP Sales | Profile | |
| Giovanni MD | Chief Officer | Profile | |
| MBA MBA | Vice Officer | Profile | |
| Jon MD | Advisor | Profile |
About Opko Health Management Performance
The success or failure of an entity such as Opko Health often depends on how effective the management is. Opko Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Opko management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Opko management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.39) | (0.41) | |
| Return On Capital Employed | (0.09) | (0.09) | |
| Return On Assets | (0.09) | (0.10) | |
| Return On Equity | (0.14) | (0.14) |
Opko Health Workforce Analysis
Traditionally, organizations such as Opko Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Opko Health within its industry.Opko Health Manpower Efficiency
Return on Opko Health Manpower
| Revenue Per Employee | 219.7K | |
| Revenue Per Executive | 54M | |
| Net Loss Per Employee | 48.1K | |
| Net Loss Per Executive | 11.8M | |
| Working Capital Per Employee | 27.8K | |
| Working Capital Per Executive | 6.8M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.191 | Earnings Share (0.19) | Revenue Per Share 0.998 | Quarterly Revenue Growth (0.03) | Return On Assets (0.09) |
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.